Christopher Bloomstran Semper Augustus Investments Group
Christopher Bloomstran is the president of Semper Augustus Investments Group, a value-oriented firm with a multi-decade focus on capital preservation and thoughtful security selection. He is known for detailed annual letters that discuss portfolio construction, accounting quality, and long-term ownership of businesses such as Berkshire Hathaway. Bloomstran’s work is popular among investors who prefer process transparency over short-term trading narratives.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jefferies Financial Group
JEF
|
+$722K |
| 2 |
WaFd
WAFD
|
+$163K |
| 3 |
AMPE
Ampio Pharmaceuticals Inc.
AMPE
|
+$67.3K |
| 4 |
Kinross Gold
KGC
|
+$6.71K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$2.82M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$2.76M |
| 3 |
Intel
INTC
|
+$2.65M |
| 4 |
Equinor
EQNR
|
+$1.17M |
| 5 |
Molson Coors Class A
TAP.A
|
+$294K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 44.31% |
| 2 | Energy | 17.76% |
| 3 | Healthcare | 10.18% |
| 4 | Materials | 10.05% |
| 5 | Technology | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRTX
26
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $498K | 0.29% |
130
| – | – |
|
|
RDS.A
27
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $401K | 0.24% |
5,212
| – | – |
|
28
Medtronic
MDT
$119B
| $319K | 0.19% |
5,000
| – | – |
|
|
AMPE
29
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $84K | 0.05% |
+33
| New | +$67.3K |
|
|
30
Molson Coors Class A
TAP.A
| – | – |
-5,000
| Closed | -$294K |
|
|
TCS
31
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| – | – |
-400
| Closed | -$204K |
|
Similar funds
Christopher Bloomstran's Q2 2014 Portfolio in Review
As of Q2 2014, Christopher Bloomstran held 31 positions worth $170M, down 1.9% from $174M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Christopher Bloomstran withdrew a net $8.98M in Q2 2014, closing 2 positions and reducing 10 holdings. Its most notable exit was Molson Coors Class A, an estimated $294K position sold in full.
By sector, the portfolio is most concentrated in Financials at 44% of assets, up from 44% a quarter earlier, followed by Energy and Healthcare.
Against the trend, Christopher Bloomstran opened a new position in Ampio Pharmaceuticals Inc. worth $84K.
- Christopher Bloomstran's largest Q2 2014 buy was Ampio Pharmaceuticals Inc.: 33 shares worth $84K.
- Christopher Bloomstran added most to Jefferies Financial Group in Q2 2014, an estimated $722K increase.
- Christopher Bloomstran's biggest Q2 2014 reduction was ExxonMobil, cutting an estimated $2.82M.
- Christopher Bloomstran fully exited Molson Coors Class A in Q2 2014, selling an estimated $294K.
- Christopher Bloomstran's ten largest holdings make up 71% of its $170M portfolio in Q2 2014.
- Christopher Bloomstran opened 1 new position and closed 2 in Q2 2014.
- Christopher Bloomstran's portfolio value fell 1.9% quarter-over-quarter to $170M.
Based on Semper Augustus Investments Group's 13F filing for Q2 2014, filed 13 Aug 2014.